Addition of Ketorolac to intramuscular local anesthesia at closure for postoperative pain management lumbar spine surgery. A prospective randomized controlled trial.

Phase 3

Recruiting

• Conditions: umbar spine surgery Postoperative pain; Lumbar spine surgery; Postoperative pain; Ketorolac; Bupivacaine; Intrawound analgesia; Multimodal analgesia

• Registration Number: TCTR20190108002
• Lead Sponsor: aresuan University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-08
• Study Completion: 2019-12-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

1. Scheduled for posterior lumbar spine fusion for 2 to 4 levels
2. Low to moderate risk for surgery

Exclusion Criteria

1. Pregnancy
2. Lactating
3. Previous lumbar spinal surgery
4. Allergic to drugs used in the study
5. History of peptic ulcer
6. Chronic kidney disease
7. Liver cirrhosis

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Morphine consumption 0-6 hours, 6-12 hours, 12-18 hours, 18-24 hours, then every 24 hours milligram

Secondary Outcome Measures

Name	Time	Method
Pain 0-6 hours, 6-12 hours, 12-18 hours, 18-24 hours, then every 24 hours Visual analog scale score ,Nausea and vomiting 0-6 hours, 6-12 hours, 12-18 hours, 18-24 hours, then every 24 hours times